The Joint Corp. (NASDAQ:JYNT – Get Free Report) major shareholder Charles Jobson purchased 1,614 shares of Joint stock in a transaction that occurred on Tuesday, November 17th. The shares were bought at an average price of $6.65 per share, for a total transaction of $10,733.10. Following the completion of the transaction, the insider owned 2,036,071 shares in the company, valued at $13,539,872.15. The trade was a 0.08% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Joint Price Performance
JYNT traded down $0.21 during trading on Thursday, hitting $6.43. 107,906 shares of the stock traded hands, compared to its average volume of 80,904. The firm has a market capitalization of $88.10 million, a P/E ratio of 32.18 and a beta of 1.16. The Joint Corp. has a 12-month low of $6.42 and a 12-month high of $10.67. The firm has a 50-day moving average of $7.41 and a 200 day moving average of $8.41.
Joint (NASDAQ:JYNT – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $13.55 million during the quarter, compared to analyst estimates of $14.85 million. Joint had a return on equity of 22.11% and a net margin of 4.81%. As a group, equities analysts predict that The Joint Corp. will post 0.31 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on JYNT. B. Riley Financial reduced their price target on Joint from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Monday, November 9th. Weiss Ratings raised Joint from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, November 11th. Finally, Wall Street Zen cut shares of Joint from a “buy” rating to a “hold” rating in a research note on Saturday, November 14th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Joint currently has an average rating of “Reduce” and an average price target of $8.00.
Read Our Latest Stock Report on Joint
Institutional Trading of Joint
Institutional investors and hedge funds have recently modified their holdings of the business. R Squared Ltd lifted its holdings in shares of Joint by 40.3% during the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock valued at $110,000 after purchasing an additional 4,284 shares in the last quarter. Susquehanna International Group LLP increased its holdings in Joint by 161.3% in the 2nd quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock worth $379,000 after buying an additional 26,626 shares in the last quarter. Squarepoint Ops LLC increased its holdings in Joint by 35.5% in the 2nd quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock worth $926,000 after buying an additional 27,633 shares in the last quarter. Verus Capital Partners LLC lifted its stake in Joint by 23.6% during the 1st quarter. Verus Capital Partners LLC now owns 130,705 shares of the company’s stock valued at $1,157,000 after acquiring an additional 24,929 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Joint by 37.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 153,754 shares of the company’s stock valued at $1,361,000 after acquiring an additional 41,842 shares during the period. Institutional investors own 76.88% of the company’s stock.
Joint Company Profile
The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company’s business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.
See Also
- Five stocks we like better than Joint
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.
